New chemical Entity Registered ( )

Similar documents
New chemical Entity Registered ( )

New chemical Entity Registered ( )

TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products

PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars

New Exception Status Benefits

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

Current and future market dynamics overview

NEW MEDICINE APPLICATIONS BROUGHT TO THE BORDERS FORMULARY COMMITTEE (BFC) AND AREA DRUG & THERAPEUTICS COMMITTEE (ADTC) 2015/16

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API

Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001

Applications received for new investments since 1 November 2008

CONTACT POLPHARMA GROUP POLPHARMA B2B

NICE TA Adherence Check List

STEP THERAPY CRITERIA

PRAC recommendations on signals

2014 DTC National Advertising Awards Finalists

NICE TA Adherence Check list April Drug Indication NICE Approval Release Date

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health

Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro

Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals

Navigating the New Options for the Management of Type 2 Diabetes

NEW MEDICINE APPLICATIONS BROUGHT TO THE BORDERS FORMULARY COMMITTEE (BFC) AND AREA DRUG & THERAPEUTICS COMMITTEE (ADTC) 2015/16

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

Drugs in Focus The early bird catches the worm! Selection of novel, still patented APIs for development activities in patent free countries

July 2014 PBAC OUTCOMES - "1 st time" decisions not to recommend. Drug Type and Use. Drug Name, form(s), strength(s), Sponsor,

AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class

Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS

PRAC recommendations on signals

INCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Side Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors. Bryce Fukunaga PharmD April 25, 2018

Pharmaceuticals and Medical Devices. Safety Information

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

A 10-year summary of kinase small molecule research Text mining AACR abstracts (white paper)

Medicines availability short-term supply issues Last updated 01/05/18

BRIAN MOSES, MD, FRCPC (INTERNAL MEDICINE) CHIEF OF MEDICINE, SOUTH WEST HEALTH

John Ansell President, John Ansell Consultancy Thame, UK

Our Values. Quality Intelligent efforts in everyday practice. Innovation Change that unlocks new value. Performance Passion for results

ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS

Very Practical Tips for Managing Type 2 Diabetes

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)

Pharmaceuticals and Medical Devices. Safety Information

PRAC recommendations on signals

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

List of Designated High-Cost Drugs

Genetics in Cancer Therapy. Raju Kucherlapati, Ph.D. Harvard Medical School

This article is a CME/CE certified activity. To earn credit for this activity visit:

Official Journal of the European Union C 401/3

Name of firm/applicant

Drugs reviewed by the SMC in September 2012 ADTC UPDATES ON DRUGS REVIEWED BY THE SMC

SUNY Binghamton, B.S. Biochemistry, 5/80 SUNY Downstate Medical Center, M.D., 6/84

LIST OF DRUGS DURING 2004

April 2015 May SMC RECOMMENDED MEDICINES FOR USE Recommended for use within NHS Scotland April 2015 May 2015 Date SMC SMC Drug Name

SUPPLEMENTARY DATA. Telediab Study Group :

NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 (UPDATE AS OF NOVEMBER 30, HIGHLIGHTED)

How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study

1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000

Update on Therapies for Type 2 Diabetes: Angela D. Mazza, DO July 31, 2015

Physician Drug Reference Chart for Diabetes Antidiabetic Medications

Oregon Health Plan prescription benefit updates

PRAC recommendations on signals

Prescription benefit updates Large group

Supplementary Appendix

Pharmaceuticals and Medical Devices Safety Information

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

Table 1. New drugs approved by the US Food and Drug Administration (FDA): December 13, 2014 through January 18, 2015

How to Fight Diabetes and Win. Diabetes. Medications

Brand companies identified in CPS or whether generic versions are available

Country of Supplying Company. Supplying Company. Anfarm Hellas S.A. Greece

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)

Opening Address: A Quick Survey Thinking 25 Years Backwards & Forwards

REGISTER OF INTERESTS SIGN guideline 154: Pharmacological management of glycaemic control in people with type 2 diabetes Published: 29 November 2017

NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd.

NATIVA GROUP. Inspired by Innovation and Technology

Aetna Better Health of Illinois Medicaid Formulary Updates

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016

A Clinical Context Report

Innovative Products Available. OTC Products Available

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018

Orphanet Rep rts Series

MEDICINES CONTROL COUNCIL

Area Drug and Therapeutics Committee Prescribing Supplement No 22 June 2008

Role of the pathologist in the diagnosis and mutational analysis of lung cancer Professor J R Gosney

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726

WellCare s South Carolina Preferred Drug List Update

CHAPTER THREE: INDUSTRY OVERVIEW... 6 HISTORICAL PERSPECTIVE OF THE MENTAL HEALTH INDUSTRY... 6 HISTORICAL PERSPECTIVE OF THE (CONTINUED)...

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

in patients with diabetes, nephropathy and/or chronic kidney disease Summary of recommendations July 2017

(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)

BRIC DIABETES DRUGS MARKET

MEDICINES CONTROL COUNCIL

Du gusts is megl che one. Edoardo Mannucci

2018 CareOregon Advantage Part D Formulary Changes

Transcription:

N# Product Name Registration Date )ل ف ) 1 Dosage form Strength Active Ingredient Marketing Authorization Holder 1 pegus 25/5/2005 tab 200 Ribavarin Shawi Roche 2 Velcade 7/7/2005 vial 3.5 bortezomib mina Janssen cilag 3 19/7/2005 Avastin Vial 100 Bevacizumab roche 4 Aranesp 18/8/2005 PFS 100mcg Darbepoetin alfa Adatco Aen 5 Abilify 15 19/9/2005 tab 15 Aripiprazole Orient Bristol Myers 6 Norprolac 75mcg 19/9/2005 tab 75mcg Quinagolide Petra drug store Ferring GmbH 7 27/11/2005 Lab 3 M Aldara 5% cream 5% imiquimod Khraim drug Store Santé/France 8 23/11/2005 Gemifloxacin Factive tab 320 mesylate Hikma Hikma 9 15/12/2005 Solifenacin Vesicare tab 10 succinate Ibn rushd Yamanoushi 10 Mycamine 10/5/2005 Vial 50 Micafungin sodium Hikma Hikma 11 3/1/2006 Eye drops Relestat solution 0.05% Epinastine Arab & Agricultura Allergen 12 Strattera 5 /2/ 2006 cap Atomoxetine Arab Drug store Eli Lilly 13 Protelos 12 /2/ 2006 powder 2gm Strontium Ranelate Jordan Les lab servier 14 Certican 19 /2/ 2006 tab 1 Everolimus Jordan Novartis pharma 15 Xoliar 21/3/2006 Inj Omalizumab Jordan Novartis pharma 16 Lyrica 5 /4/ 2006 cap 25 Pregabalin Alsabbagh Pfizer 17 9 /5/ 2006 Powder for conc Alimta for sol for infusion 25/ml Pemetrexed Arab Drug store Eli Lilly 18 30 /5/ 2006 Sol for inj in Apidra vial 100IU/ml Insulin glulisine Ulfa Aventis Pharma

19 Levemir penfill 5 /6/ 2006 Sol for inj 100IU/ml Insulin detemir Khoury NovoNnordisk 20 Exjade 20 /6/ 2006 Dispersible tab 250 deferasirox Jordan Novartis pharma 21 31 /7/ 2006 Methylphenidate ncerta tab 36 HCl Ninos Janssen cilag 22 30 /8/ 2006 nc for sol for Mabcampath infusion 30/ml Alemtuzumab Jordan drug store Schering AG 23 19/12/2006 nc for sol for Aldurazyme infusion 100IU/ml laronidase الزراعية Genzyme 24 14 /1/ 2007 Duloxetine Hcl 60 Eli Lilly Export Cymbalta CAP 60 The Arab S.A 25 16 /1/ 2007 Oxcarbazepine 60 Trileptal tab 300 /ml 26 Baraclude tab 18 /1/ 2007 tab 1 Entecavir Orient 27 Meiact tab 14 /2/ 2007 Tab 200 Cefditoren Sukhtian Tabuk 28 Zymar 28 /3/ 2007 Opth. solu 0.3% Gatifloxacin الزراعية Allergen 29 15 /7/ 2007 Les Laboratories Procoralan TAB 5 Ivabradine 5 Servier 30 12 /8/ 2007 Carbetocin 100 Pabal INJE 100 ug/ml ug/ml Petra Ferring GmbH 31 23 /9/ 2007 0.50%,40 Timolol 0.50 %, Duotrav EAR Drop ug Travaprost 40 Modern Alcon-uvreur 32 2 /10/ 2007 Ranibizumab 10 Lucentis SOLU 10 /ml /ml 33 Champix 0.5 11/10/ 2007 TAB 0.5 Varenicline 0.5 Sabbagh Pfizer 34 18/11/ 2007 Telbivudine 600 Sebivo TAB 600 35 10 /2/ 2008 Loteprednol Bausch & Lomb Lotemax SUSP 0.5 % Etabonate 0.5 % Petra Incorporated

36 28 /2/ 2008 Cladribine 10 Litak VIAL 10 /5ml /5ml Al Wafi Lipomed AG 37 23 /3/ 2008 Meropenem Meronem 1gm inj 1 gm Trihydrate 1 gm AstraZeneca 38 Invega Extended Release 9 /4/ 2008 TAB 6 Paliperidone 6 Telegraph Janssen Cilag 39 20 /4/ 2008 ORIENT DRUG Bristol Myers Sprycel 20 TAB 20 Dasatinib 20 STORE CO Squibb 40 27 /4/ 2008 Mitiglinide Glufast TAB 5 Calcium Hydrate5 Hikma Pharmaceuticals Hikma Pharmaceuticals 41 20 /5/ 2008 Suleiman Tannous & Relenza tab 5 Zanamivir 5 Sons. Ltd GSK 42 22 /5/ 2008 Levobupicacaine Walid Al Turk Drug Chirocaine Amp Amp 2.5 /ml Hcl 2.5/ml Store Abbott 43 27 /7/ 2008 Memantine Hcl 10 Abu Sharef Medical H-Lundbeck A/S Ebixa TAB 10 Stors overseas 44 4 /8/ 2008 300/15m Natalizumab 300 Tysabri SOLU l /15ml Adatco Elan Pharma 45 27 /8/ 2008 Adefovir Dipivoxil Suleiman Tannous & Hepsera TAB 10 10 Sons. Ltd GlaxoWellcome 46 2 /9/ 2008 Sorafenib Tosyllate Nexavar TAB 200 200 Khoury Bayer AG 47 22 /11/ 2008 Gadoversetamide 330.9 330.9 g/ml Optimark 0.5mmol/ml(20ml) INJE /ml Sabbagh Mallinckrodt 48 24 /11/ 2008 49 Tasigna Cubicin 14 /12/ 2008 CAPS 200 Nilotinib 200 Daptomycin 350 Powder 350 Roche Pharma novartis

50 24 /12/ 2008 Rasilez tab TAB 300 Aliskiren 300 novartis 51 Januvia 31 /12/ 2008 TAB 100 Sitagliptin 100 Adatco Merck &.Inc 52 12 /1/ 2009 Valganciclovir 450 F.Hoffmann La- Valcyte F.C.Tablet TAB 450 Roche 53 8 /4/ 2009 Tarceva F.C.Tablet TAB 100 Erlotinib 100 roche 54 5 /5/ 2009 Suleiman Tannous & Tykerb TAB 250 Lapatinib 250 Sons. Ltd Glaxo Group Ltd 55 7 /12/ 2009 Rivaroxaban Xarelto TAB 10 Micronized 10 Khoury Bayer Health Care 56 Firmagon vial 20/6/2010 Powder& solvent for Degarelix solution for inj 80 Petra drug store Ferring 28/11/2010 Solution for Sugammadex 57 Bridion injection 100/ml Adatco N.V Organon 10/2/2011 Jordan 58 Valdoxan Agomelatine. tab 25 Servier 59 13/11/2011 capsules Jordan Onbrez Breezhaler containing a powder for 150 and 300 Indacaterol maleate Novartis inhalation micrograms 60 Victoza 28/11/2011 Solution for inj in PFP 6 /ml Liraglutide Khoury Novo Nordisk

61 62 Multaq F.C tab IBD: 31/7/2009 Submission date:14/10/2010 Prolia. IBD: 26/5/2010 Submission date:16/12/2010 63 Onglyza IBD: 31/7/2009 Submission date:27/1/2011 19/6/2012 4/3/2012 F.C tab Solution for inj in PFP 400 60/ml 17/5/2012 Tab 5 Dronedarone Denosumab Saxagliptin Ulfa Adatco drug store Sanofi Aventis Aen Astrazeneca Gilenya 64 IBD: 17/8/2010 Submission date:28/4/2011 65 Brilinta IBD: 3/12/2010 Submission date:12/5/2011 Jevtana vial 66 IBD: 17/8/2010 Submission date:28/4/2011 67 Zytiga IBD: 28/4/2011 Submission date:26/1/2012 68 Brinavess IBD: 9/2010 Submission date:27/10/2011 15/4/2012 11/7/2012 22/1/2013 10/11/2013 14/3/2013 Cap 0.5 Fingolimod Tab 90 Ticagrelor Novartis Astrazeneca conc. & solvent for infusion. 60 Cabazitaxel Ulfa Sanofi Tablet 250 Abitraterone Acetate Telegraph Janssen-Cilag Inernational ncentrate for Solution for infusion 20/ml Vernakalant Hcl Adatco drug store MSD LTD

69 Trajenta IBD: 20/5/2011 Submission date: 6/11/2012 70 Incivo IBD: 23/5/2011 Submission date:13/3/2012 71 Victrelis IBD : 13/5/2011 Submission date : 19/2/2012 72 Stivarga IBD : 27/9/2012 Submission date : 14/8/2013 mmission decision date : 2/4/2014 73 Eylea IBD : 18/11/2011 Submission date : 4/4/2013 mmission decision date : 21/5/2014 74 Signifor IBD : 24/4/2012 Submission date : 20/5/2013 mmission decision date : 5/11/2014 9/10/2013 21/10/2013 21/7/2013 20/5/2014 6/7/2014 8/2/2015 tablet 5 Linagliptin Arab drug store (shqer) tablet 375 Telaprevir Ninos drug store Hard capsule 200 Boceprevir Adatco drug store tablet 40 Regorafinib Khori drug store Solution for injection 40 /ml aflibercept Khori drug store Solution for injection 0.3 /ml 0.6 /ml 0.9/ml Pasireotide Dispartate Boehringer Ingelheim International GmbH,Ingelheim am Rhein Janssen-Cilag international MSD/Ltd UK Bayer Pharma A G / Germany Bayer Pharma A G / Germany /Switzerland

75 Zelboraf IBD : 17/8/2011 Submission date : 14/10/2012 mmission decision date : 19/11/2014 76 Lyxumia IBD : 7/1/2013 Submission Date : 28/11/2013 mmission decision date : 5/8/2015 77 Exviera IBD : 15/1/2015 Submission Date : 10/2/2015 mmission decision date : 12/8/2015 78 Viekirax IBD : 15/1/2015 Submission Date : 10/2/2015 mmission decision date : 19/8/2015 80 Giotrif IBD : 2/7/2013 Submission Date : 29/9/2014 mmission decision date : 16/9/2015 4/2/2015 9/12/2015 30/8/2015 30/9/2015 26/11/2015 tablet 240 Vemurafenib Pre-filled Pen 10mcg 20mcg 10&20 mcg Lixisenatide Ulfa Tablet 250 Dasabuvir Tablet 12.5 75 50 Ombitasvir Paritaprevir Ritonavir tablet 20 Afatinib Abu sheikha drug store Abu sheikha drug store Arab drug store (shqer) F.hoffman la-roche /Switzerland Sanofi avemtis groupe/ France Abbvie limited / UK Abbvie limited / UK Boehringer ingelheim international / Germany Last reviewed in 12/12015 في حال الحاجة لالعتراض على محتويات القائمة ارجو ارسال كتاب رسمي لقسم التسجيل.